ChromaDex

ChromaDex is a dietary supplement and food ingredient company based in Irvine, California founded in 1999 that is publicly traded on the NASDAQ. ChromaDex has licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line. In 2011, Cornell University announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Niagen.ChromaDex also offers contract research services that help customers source raw materials, identify new compounds and develop processes for large scale manufacturing.As of 2012 American billionaire and pharmaceutical entrepreneur Phillip Frost owned approximately 19% of ChromaDex.ChromaDex sells ingredients to third parties that market them under their own labels.